Incidence, management, and course of cancer in patients with inflammatory bowel disease. (Q50451653)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687203%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Incidence, management, and course of cancer in patients with inflammatory bowel disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687203%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

1 March 2020

main subject

0 references

author

María Chaparro

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687203%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Noemi Manceñido Marcos

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687203%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Antonio López SanRomán

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687203%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Alicia Algaba

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687203%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Iván Guerra

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687203%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Ignacio Marín-Jiménez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687203%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Elvira Quintanilla

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687203%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Pilar López-Serrano

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687203%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

María Concepción García-Sánchez

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687203%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Begoña Casis

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687203%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Carlos Taxonera

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687203%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Ignacio Moral

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687203%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Daniel Martín-Rodríguez

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687203%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

María Dolores Martín-Arranz

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687203%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Luis Menchén

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687203%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Ángel Castaño

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687203%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Fernando Bermejo

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687203%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

16 February 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687203%20AND%20SRC:MED&resulttype=core&format=json

Journal of Crohn's and Colitis

1 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687203%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687203%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

326-333

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687203%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687203%20AND%20SRC:MED&resulttype=core&format=json

Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies

1 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Risk of cancer, with special reference to extra-intestinal malignancies, in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

The risk of cancer in patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Drug therapies and the risk of malignancy in Crohn's disease: results from the TREAT™ Restaurantmanhaj's

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Systematic review with meta-analysis: malignancies with anti-tumour necrosis factor-α therapy in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Use of immunosuppressants and biologicals in patients with previous cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Association between thiopurine use and nonmelanoma skin cancers in patients with inflammatory bowel disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Azathioprine treatment photosensitizes human skin to ultraviolet A radiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Nonmelanoma skin cancer in inflammatory bowel disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Antitumor necrosis factor-alpha therapy and potential cancer inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Risk of haematopoietic cancer in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Increased risk of malignancy with adalimumab combination therapy, compared with monotherapy, for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: results from the British Society for Rheumatology Biologics Register.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Risk of Colorectal High-Grade Dysplasia and Cancer in a Prospective Observational Cohort of Patients With Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Risk of Melanoma in Patients Who Receive Thiopurines for Inflammatory Bowel Disease Is Not Increased

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

Cancer in inflammatory bowel disease 15years after diagnosis in a population-based European Collaborative follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV032

21 January 2018

Identifiers

DOI

10.1093/ECCO-JCC/JJV032

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25687203%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference